Table 2.

Estimated total dietary intake of acrylamide (energy-adjusted using the residual method) and covariates at baseline used in the analyses: EPIC subcohort (325,006 women)

Energy-adjusted acrylamide intake, μg/d
<14.614.7–19.619.7–24.424.5–32.332.4–222.4
Participants65,00165,00165,00265,00165,001
EOC cases221207219280264
Energy-adjusted acrylamide intakea, μg/d10.8 (7.6–13.0)17.2 (16.0–18.4)21.9 (20.7–23.1)27.7 (25.9–29.8)39.5 (35.4–45.9)
Age at recruitmenta51.0 (45.5–57.1)50.4 (45.3–56.9)50.2 (44.5–56.6)50.6 (43.8–57.5)51.7 (43.5–58.0)
Age at menopausea,b50.0 (47.0–52.0)50.0 (47.0–52.0)50.0 (46.0–52.0)50.0 (46.0–52.0)50.0 (46.0–52.0)
Menopausal status at baseline (%)
 Premenopausal35.034.136.137.436.9
 Postmenopausal45.243.842.644.247.5
 Perimenopausal19.822.121.318.515.7
Ever use of OCs (%)
 Yes49.0755.6358.1161.3864.89
 Unknown0.642.424.323.701.71
Parity (%)
 Nulliparous12.211.912.616.019.4
 1 child17.5814.6113.6513.3913.39
 2 children41.5739.9438.6436.5236.02
 ≥3 children25.3527.2926.3625.0323.64
 Parous but with missing number of full-term pregnancies0.40.91.63.35.3
 Unknown2.95.47.15.72.3
Smoking status (%)
 Never59.960.055.452.349.6
 Former19.520.923.024.325.4
 Current18.515.618.921.323.8
 Unknown2.23.42.82.11.2
Cigarettes per daya,b (smokers only)11.0 (6.0–20.0)10.0 (8.0–20.0)10.0 (10.0–20.0)10.0 (10.0–20.0)15.0 (10.0–20.0)
Time since quitting smokinga,b,c, y12.5 (6.5–20.0)14.5 (7.0–22.0)14.5 (6.5–22.0)14.5 (6.5–22.0)14.0 (6.0–22.5)
BMIa, kg/m224.3 (21.9–27.4)23.8 (21.6–26.8)24.0 (21.8–27.0)24.1 (21.9–27.1)24.3 (22.0–27.3)
Energya, kcal/d2,033.7 (1,684.4–2,444.0)1,803.9 (1,487.8–2,167.6)1,750.3 (1,441.8–2,113.0)1,813.6 (1,509.0–2,172.1)1,966.1 (1,655.0–2,335.1)
  • aMedian and quartile range (25th–75th percentile).

  • bPercentage of women missing the following: age at menopause, 66%; number of cigarettes per day, 55%; and time since quitting smoking, 55%.

  • cOnly in former smokers.